SCHEMBL7652890

SCHEMBL7652890

CCC(C(=O)Nc1ccc(N2CCCCC2)nc1)c1ccncc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 7/20 0.55
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
HDAC3 O15379 3/20 0.47
HDAC1 Q13547 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
HDAC4 P56524 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
KCNQ3 O43525 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
KCNE1 P15382 1/20 0.47
KCNQ1 P51787 1/20 0.47
KCNQ4 P56696 1/20 0.47
TRPV1 Q8NER1 1/20 0.46
FASN P49327 1/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651621 0.85 KCNQ2 (0.47) KCNQ2SMN1; SMN2KCNQ3CYP1A2TRPV1
SCHEMBL1593512 0.81 KMT2A (0.58) KCNQ2SMN1; SMN2KCNQ3TRPV1FASN
SCHEMBL1593906 0.80 KCNQ3 (0.50) KCNQ2SMN1; SMN2HTTKCNQ3TRPV1
SCHEMBL7654539 0.76 AOC3 (0.56) KCNQ2SMN1; SMN2KCNQ3TRPV1ALDH1A1
SCHEMBL1593432 0.75 KMT2A (0.64) KCNQ2SMN1; SMN2KCNQ3CYP1A2TRPV1
SCHEMBL24645772 0.74 MAPT (0.67) KCNQ2SMN1; SMN2KCNQ3CYP1A2CYP3A4
SCHEMBL1594391 0.73 KMT2A (0.66) KCNQ2SMN1; SMN2KCNQ3CYP1A2TRPV1
SCHEMBL4969527 0.71 KCNQ3 (0.60) KCNQ2SMN1; SMN2LMNAHTTKCNQ3
SCHEMBL22777899 0.70 KDM4E (0.60) KCNQ2HTTKCNQ3TRPV1GAA
SCHEMBL7651646 0.70 HTT (0.67) KCNQ2SMN1; SMN2LMNAHTTHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed